|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.110 CNY | -2.29% |
|
+2.00% | -0.20% |
| 07-16 | Jointown Pharmaceutical's Two Drugs Added to China's Essential Medicines List | MT |
| 06-11 | Jointown Pharma Issues 1 Billion Yuan in Asset-Backed Securities | MT |
| Market Cap | 25.48B 3.76B 3.29B 3.03B 2.79B 5.27B 362B 5.38B 36.23B 14.25B 177B 14.12B 13.81B 610B | P/E 2026 * |
10.9x | P/E 2027 * | 10.1x |
|---|---|---|---|---|---|
| Enterprise Value | 21.16B 3.12B 2.73B 2.52B 2.32B 4.37B 301B 4.47B 30.09B 11.83B 147B 11.72B 11.47B 507B | EV / Sales 2026 * |
0.12x | EV / Sales 2027 * | 0.11x |
| Free-Float |
43.03% | Yield 2026 * |
4.09% | Yield 2027 * | 4.36% |
| 1 day | -2.29% | ||
| 1 week | +2.00% | ||
| Current month | +8.96% | ||
| 1 month | +7.35% | ||
| 3 months | -2.85% | ||
| 6 months | -2.67% | ||
| Current year | -0.20% |
| 1 week | 4.98 |  | 5.28 |
| 1 month | 4.48 | | 5.28 |
| Current year | 4.48 | | 5.84 |
| 1 year | 4.48 | | 5.84 |
| 3 years | 4.35 | | 6.94 |
| 5 years | 3.97 | | 6.94 |
| 10 years | 3.97 | | 8.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wei He
CEO | Chief Executive Officer | 40 | 22/04/2022 |
Xiao Yi Xia
DFI | Director of Finance/CFO | 48 | 14/11/2023 |
Xi Zhang
IRC | Investor Relations Contact | - | 22/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhao Nian Liu
BRD | Director/Board Member | 66 | 15/11/2008 |
Deng Pan Liu
BRD | Director/Board Member | 48 | 04/11/2020 |
Yi Hua Gong
BRD | Director/Board Member | 48 | 30/06/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.29% | +2.00% | -5.37% | -5.93% | 3.85B | |
| +0.01% | +4.40% | +18.46% | +104.38% | 98.5B | |
| -0.09% | -3.09% | +43.31% | +144.48% | 53.57B | |
| -0.34% | +3.90% | +5.40% | +283.01% | 23.68B | |
| -2.52% | +2.98% | -13.40% | -21.43% | 8.45B | |
| -5.82% | +2.45% | -31.50% | -31.90% | 8.27B | |
| -1.35% | +5.02% | -6.44% | -25.07% | 7.09B | |
| +2.44% | +0.89% | +25.25% | +34.78% | 6.18B | |
| +0.79% | +2.77% | -0.17% | +25.74% | 5.45B | |
| +1.62% | +8.06% | +16.46% | +23.26% | 3.53B | |
| Average | -0.76% | +1.99% | +5.20% | +53.13% | 21.86B | |
| Weighted average by Cap. | -0.34% | +2.17% | +18.48% | +112.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 170B 25.05B 21.89B 20.2B 18.62B 35.1B 2,412B 35.87B 241B 94.97B 1,181B 94.08B 92.01B 4,067B | 180B 26.53B 23.18B 21.39B 19.72B 37.17B 2,555B 37.99B 256B 101B 1,251B 99.63B 97.44B 4,307B |
| Net income | 2.36B 348M 304M 280M 258M 487M 33.47B 498M 3.35B 1.32B 16.39B 1.31B 1.28B 56.43B | 2.56B 377M 330M 304M 281M 529M 36.35B 541M 3.64B 1.43B 17.8B 1.42B 1.39B 61.28B |
| Net Debt | -4.32B -637M -557M -514M -474M -893M -61.39B -913M -6.14B -2.42B -30.07B -2.39B -2.34B -104B | -5.04B -744M -650M -600M -553M -1.04B -71.65B -1.07B -7.17B -2.82B -35.09B -2.79B -2.73B -121B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | CN¥5.110 | -2.29% | 47,920,079 |
| 16/07/26 | CN¥5.230 | +1.36% | 57,762,090 |
| 15/07/26 | CN¥5.160 | -0.96% | 53,342,812 |
| 14/07/26 | CN¥5.210 | +2.96% | 77,010,061 |
| 13/07/26 | CN¥5.060 | +1.00% | 46,963,570 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600998 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
